Legislative Information

Louisiana Legislative Information

www.legis.state.la.us
Click to view the web portal to the Louisiana legislature. Search for a bill, find your representative and research current Louisiana laws.


National Legislative News & Information

www.ashp.org/advocacy/
Link to the American Society of Health-System Pharmacists Advocacy Site

www.congress.org
Click above to find your US Representative or Senate & search current Congressional bills or call the Capitol switchboard at (202) 224-3121 to be connected to any congressional office.

Legislative Alerts

Action Alert: April 11, 2017

4/11/2017

Notice of Rulemaking Activity from the Louisiana Board of Pharmacy

Notices of Intent - Regulatory Projects 2017-1 & 2017-2

Regulatory Project 2017-1
The Board has initiated the rulemaking process to amend its rules relative to pharmacy interns and the hours of practical experience required for pharmacist licensure.  The Board proposes to update its rules to recognize current pharmacy education accreditation standards for such practical experience and simplify that portion of the requirements for pharmacist licensure.  The Board has filed its 1st Report to the Joint Legislative Oversight Committee on Health & Welfare.  The Notice of Intent is scheduled for publication in the April 20, 2017 edition of the Louisiana Register; as indicated in that notice, the Board has scheduled a public hearing on May 30, 2017 to receive comments and testimony on the proposed rule.
 
Regulatory Project 2017-2
The Board has initiated the rulemaking process to amend its rules relative to equivalent drug product interchange, as required by Act 391 of the 2015 Regular Legislative Session.  The proposed rule will require pharmacists dispensing certain interchangeable biological products to communicate certain information about the product dispensed to the prescribing practitioner.  The Board has filed its 1st Report to the Joint Legislative Oversight Committee on Health & Welfare.  The Notice of Intent is scheduled for publication in the April 20, 2017 edition of the Louisiana Register; as indicated in that notice, the Board has scheduled a public hearing on May 30, 2017 to receive comments and testimony on the proposed rule.
 
For the Board:
Malcolm J. Broussard
Executive Director


Action Alert: March 29, 2017

3/29/2017

Notice of Rulemaking Activity from the Louisiana Board of Pharmacy

Second Report to Joint Legislative Oversight Committee on Health and Welfare

Regulatory Project 2016-4 - Standing Orders for Distribution of Naloxone
Authorized by Act 370 of the 2016 Legislature, the proposed rule will allow pharmacists to distribute naloxone and other opioid antagonists pursuant to non patient-specific standing orders issued by medical practitioners with prescriptive authority for naloxone.  After publishing the Notice of Intent in the January 2017 edition of the Louisiana Register, the Board held a public hearing on March 1 to receive comments and testimony on the proposed rule.  The Board received no comments or testimony on the proposed rule.  The Board considered the absence of comments and testimony duirng their subsequent meeting on March 14 and determined no further revisions to the original proposed rule were necessary.  The Board has filed its 2nd Rep ort to the Joint Legislative Oversight Committee on Health and Welfare.  Subject to review by the committee, the Board proposes to publish the original proposed rule as a Final Rule in the May 20, 2017 edition of the Louisiana Register with an immediate effective date, at which time the currently-pending Emergency Rule will be cancelled.

Regulatory Project 2016-5 - Reinstatement of CDS License
The Board has proposed an amendment to its current rule relative to the reinstatement process for CDS licenses held by medical practitioners where the Board has suspended or revoked the CDS license pursuant to disciplinary action on the underlying medical license by the medical licensing agency.  After publishing the Notice of Intent in the January 2017 edition of the Louisiana Register, the Board held a public hearing on March 1 to receive comments and testimony on the proposed rule amendment.  The Board received no comments or testimony on the proposed rule amendment.  The Board considered the absence of comments and testimony during their subsequent meeting on March 14 and determined no further revisions to the original proposed rule amendment were ncessary.  The Board has filed its 2nd Report  to the Joint Legislative Oversight Committee on Health and Welfare.  Subject to review by the committee, the Board proposes to publish the original proposed rule amendment as a Final Rule in the May 20, 2017 edition of the Louisiana Register with an immediate effective date, at which time the currently-pending Emergency Rule will be cancelled.
 
For the Board:
Malcolm J. Broussard
Executive Director


Public Health Alert: 1/24/2017

1/24/2017

Public Health Alert

Statewide Standing Order for Distribution of Naloxone and Other Opiod Antagonists

Dr. Rebekah Gee, MD, MPH, Secretary of Louisiana Department of Health has signed and issued a statewide standing order authorizing pharmacists to distribute naloxone or other opioid antagonists to anyone who wants to keep the drug available to assist any person suffering an opioid overdose event.  This statewide order is valid for any Louisiana-licensed pharmacy dispensing or distributing the opioid antagonist to any Louisiana resident.  This order will expire on January 23, 2018.  A copy of the standing order is available here .

For the Board:
Malcolm J Broussard
Executive Director